The fibrosis and cirrhosis seen after MTX therapy in some liver biopsies from psoriatics and the post-MTX increase in the number of Ito cells direct attention to the possible role of Ito cells as fibroblast precursors.
The sinusoids of the liver are lined with endothelial cells, Kupffer cells, and the fat-containing lipocyte or Ito cell. These last cells are not well known, even though they were first described by von Kupffer (1875) and rediscovered by Maximow (1927) . More recently, they have been characterized by Ito and Nemoto (1956) . Fahimi (1970) Bronfenmajer, et al (1966) . The physiological function of Ito cells remains obscure, although they may be related to vitamin A storage (Hruban et al, 1974) . Various drugs have been found to increase the number of Ito cells present in the liver, including methotrexate (MTX) (Horvath et al, 1973) .
MTX therapy has been reported to clear recalcitrant psoriasis vulgaris in 60-70 % of cases (Roenigk et al, 1969; Nyfors and Brodthagen, 1970) . Case reports of liver disease, particularly cirrhosis, observed after MTX therapy have aroused concern (Coe and Bull, 1968; Muller et al, 1969; Dahl et al, 1971) . Prospective studies, including liver biopsy in Received for publication 4 November 1975 psoriatics before and after MTX therapy and in the same patient at intervals during MTX therapy, have been undertaken (Weinstein et al, 1973; Nyfors and Poulsen, 1974 Clinical and laboratory data concerning these patients are described elsewhere (Nyfors and Poulsen, 1976a, b) . MTX was given orally once a week in a single dose of up to 25 mg.
LABORATORY TESTS
Liver function tests-serum aspartate aminotransferase (SGOT), alkaline phosphatase, and serum bilirubin were taken the day before liver biopsy and at varying intervals during MTX therapy. LIGHT 
MICROSCOPY
Parts of each liver biopsy were taken for conventional light microscopy. The remainder of the biopsy was cut into 1 mm cubes, fixed in 4% glutaraldehyde at pH 7-2, and post osmicated and embedded in Araldite. 1 pum sections were stained with toluidine blue and examined under oil (x 1000). Ito cells containing numbers of small, blue-green lipid droplets can be recognized easily along the sinusoids.
POINT COUNTING
The volume density of the Ito cells in the liver was determined by point counting, using a 400 point array eyepiece graticule. Toluidine blue stained 1 plastic-embedded sections of the biopsies were used, at least five being examined from each biopsy. Ten consecutive non-overlapping fields were counted under oil with a x 10 eyepiece and a x 100 objective from each slide. The number of points falling on Ito cells and the number of cells within the graticule were recorded. The point counts are directly proportional to the Ito cells' volume in the liver.
The theoretical accuracy of the point counting can be estimated using the equation given by Weibel (1963) :
where PT is the number of points counted, Vv the volume density of the Ito cells, and EV, the error.
Preliminary counts showed that the volume density of the Ito cells before therapy was about 0-25 %. If 30 000 points are counted this gives an error of 10 %.
Similarly, after methotrexate therapy, if 20 000 points are counted this gives an error of 5 5%forthe volume density which rose to about 0 7 %.
The Ito cell index was also determined using oil immersion ( (Siegel, 1956) . One-tailed probabilities were used.
Results

PATIENTS
The average age of the patients (8 males, 16 females) was 47 (range 25-77) years at the first liver biopsy, and the mean duration and extent (per cent of skin surface involved) of psoriasis was 21 (range 3-37) years and 27 % (range 4-95 %), respectively. The mean cumulative dose of MTX was 1810 mg (range 528-3218 mg), while the average duration of MTX therapy was 28 (range 5-41) months. The time between the last intake of MTX and the second liver biopsy was less than one week in 11, less than one month in 1, 1-4 months in 2, while it varied from 157 to 1120 days in the remaining patients. (Bronfenmajer et al, 1966) . The general properties of the cells are those described previously by Ito and Nemoto (1956) . The point counting technique used showed that the volume density of the Ito cells in the normal liver biopsies had a mean of 0-25%. Immediately after treatment this rose to a mean of 0-66 %, falling back to pre-therapy values by 100 days. The increase in volume density is due to hyperplasia and hypertrophy of the Ito cells. These cells were not estimated in the study of Weibel and Bolender (1973) .
The problems of estimating small populations of infrequently occurring cells and organelles are well known (Weibel and Bolender, 1973) .
Various methods have been used to assess Ito cells previously. Bronfenmajer et al (1966) (Bronfenmajer et al, 1966) . None of our patients had these diseases. Bronfenmajer et al (1966) described an increase in the number of Ito cells after prolonged steroid therapy. We saw this in two of our patients who were D. Hopwood and A. Nyfors receiving corticosteroids (258, 302) . Other drugs, such as chlorpromazine (Bronfenmajer et al, 1966) and chenodeoxycholic acid (Hopwood, et al, in preparation) , have been reported to cause an increase in the number of Ito cells. We found that MTX produces an increase in Ito cells, confirming the report of Horvath et al (1973) . An excess of vitamin A intake has been shown to create an increase in the number of Ito cells in the human liver (Hruban et al, 1974) .
The function of Ito cells is not clear, but the various theories of their origin have been reviewed by Hruban et al (1974) . They believe that the Ito cell plays a role in the storage of vitamin A although there is evidence contrary to this (Hori and Kitamura, 1972) . Hruban et al (1974) also pointed out that Ito cells may be fibroblast precursors, possibly related to the fibrosis and cirrhosis which may develop in hypervitaminosis A. Whether this mechanism may play a role in the fibrosis and cirrhosis reported following MTX therapy (Dahl et al, 1971; Nyfors and Poulsen, 1974 ) is open to question. Certainly, McGee and Patrick (1972) believe that the Ito cell has greater potential than the storing of fat. How else do the present results fit in with the known function of Ito cells? At the moment one can only say that MTX is an example of another drug which causes an increase in the number of Ito cells in the liver. When more examples are known then a mechanism for Ito cell hyperplasia may become apparent and their normal role may be better understood.
